[1] VINODH G,VENKATESAN CS,JAYA SA,et al.Novel degradation products of argatroban:Isolation,synthesis and extensive characterization using NMR and LC-PDA-MS/Q-TOF[J].J Pharm Anal,2018,8(2):86
[2] LIONEL P,ANME CS,ELENA F,et al.Determination of inhibitory potency of argatroban toward thrombin by electrophoretically mediated microanalysis[J].Talanta,2013,116:719
[3] PHILIPPE HS,MAHER K,MELISANDE B,et al.Photodegradation of aqueous argatroban investigated by LC/MS:photoproducts,transformation processes and potential implications[J].J Pharm Biomed Anal,2016,131:223
[4] NORIAKI T,KENICHI T,MICHIO M,et al.Management of intra-aortic balloon counterpulsation by argatroban anticoagulation in a patient with a history of heparin-induced thrombocytopenia[J].J Cardiol Cases,2012,6(5):154
[5] FAREED J,JESKE W.Small molecule direct antithrombins:argatroban[J].Best Pract Res Clin Haematol,2004,17(1):127
[6] 谢智乾,王哲烽,时惠麟.阿加曲班一水合物合成路线图解[J].中国医药工业杂志,2011,42(11):868 XIE ZQ,WANG ZF,SHI HL.Graphical synthetic routes of argatroban monohydrate[J].Chin J Pharm,2011,42(11):868
[7] 刘克垒,康彦龙,李菁,等.阿加曲班的合成[J].中国医药工业杂志,2015,46(11):1161 LIU KL,KANG YL,LI J,et al.Synthesis of argatroban[J].Chin J Pharm,2015,46(11):1161
[8] EUROPEAN MEDICINES AGENCY.Guidelines on the limits of genotoxic impurities[EB/OL].[2016-12-05].http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002903.pdf
[9] US FOOD AND DRUG ADIMMINISTRATION.Guidance for industry.Genotoxic and carcinogenic impurities in drug substancesand products:recommended approaches[EB/OL].[2016-12-05].http://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2008-D-0629-gdl.pdf
[10] 李开凤,普俊学,高宏涛.HPLC法测定盐酸法舒地尔中基因毒性杂质[J].海峡药学,2018,30(2):45 LI KF,PU JX,GAO HT.Determination of genotoxic impurity in fashudil hydrochloride by HPLC[J].Strait Pharm J,2018,30(2):45
[11] 樊春艳,谢学渊,任婷麟,等.HPLC法测定盐酸法舒地尔有关物质的应用价值[J].西部医学,2014,26(7):930 FAN CY,XIE XY,REN TL,et al.Application value of determination of fasudil hydrochloride related substances by HPLC[J].Med J West China,2014,26(7):930
[12] 王珊珊,宁凡盛,王晓利,等.HPLC-MS/MS法分析吉非替尼中痕量基因毒性杂质[J].药物分析杂志,2017,37(7):1309 WANG SS,NING FS,WANG XL,et al.Trace determination of genotoxic impurity in gefitinib by HPLC-MS/MS[J].Chin J Pharm Anal,2017,37(7):1309
[13] 宋凡,宋晓妮,王磊,等.酒石酸伐尼克兰中6个类苯胺基因毒性杂质的LC-MS法测定[J].药物分析杂志,2018,38(1):130 SONG F,SONG XN,WANG L,et al.Determination of six aniline-like genotoxic impurities in varenicline tartrate by LC-MS[J].Chin J Pharm Anal,2018,38(1):130
[14] 钱建钦,张云峰,王建,等.UHPLC-MS法测定2种硫酸氢氯吡格雷晶型中的基因毒性杂质对甲苯磺酸甲酯[J].药物分析杂志,2017,37(11):1994 QIAN JQ,ZHANG YF,WANG J,et al.Determination of genotoxic impurity methyl p-toluenesulfonate in two kinds of crystal forms of clopidogrel hydrogen sulfate[J].Chin J Pharm Anal,2017,37(11):1994
[15] 陈菁菁,杨小玲,李琴.UPLC-QTOF/MS法分析盐酸奈必洛尔中痕量遗传毒性杂质A和B[J].药物分析杂志,2016,36(11):2035 CHEN JJ,YANG XL,LI Q.Trace determination of genotoxic impurities A and B in nebivolol hydrochloride by UPLC-QTOF/MS[J].Chin J Pharm Anal,2016,36(11):2035
[16] 周长朋,王东武,张曼玉,等.高效液相色谱-四极杆/线性离子阱质谱仪测定盐酸决奈达隆中两种基因毒性杂质的痕量残留[J].分析测试学报,2016,35(9):1111 ZHOU CP,WANG DW,ZHANG MY,et al.Determination of two genotoxic impurities residues in dronedarone hydrochloride by HPLC-QTRAP-MS/MS[J].J Instrm Anal,2016,35(9):1111